RYAN ARTHUR F 1187443 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-02 | 2023-06-01 | 2023-06-01 | 4 | Ryan Arthur F | DIRECTOR | dsp | 100.0 | 0.53 | 0.01 | 735.42 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 18847.0
|
107.89 (REGN) |
| 2023-08-03 | 2023-08-01 | 2023-08-01 | 4 | Ryan Arthur F | DIRECTOR | dsp | 100.0 | 0.53 | 0.01 | 736.59 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 18647.0
|
107.89 (REGN) |
| 2023-11-08 | 2023-11-07 | 2023-11-07 | 4 | Ryan Arthur F | DIRECTOR | dsp | 100.0 | 0.54 | 0.01 | 827.9 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 18547.0
|
107.13 (REGN) |
| 2023-12-04 | 2023-12-01 | 2023-12-01 | 4 | Ryan Arthur F | DIRECTOR | dsp | 100.0 | 0.54 | 0.01 | 817.3 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 18447.0
|
107.13 (REGN) |
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Ryan Arthur F | DIRECTOR | dsp | 100.0 | 0.54 | 0.01 | 899.9 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 18347.0
|
107.13 (REGN) |
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Ryan Arthur F | DIRECTOR | acq | 135.0 | 0.73 | 0.01 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code A | 18482.0 | 107.13 (REGN) |
| 2024-02-05 | 2024-02-01 | 2024-02-01 | 4 | Ryan Arthur F | DIRECTOR | dsp | 100.0 | 0.54 | 0.01 | 954.22 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 18382.0
|
107.13 (REGN) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Ryan Arthur F | DIRECTOR | dsp | 100.0 | 0.54 | 0.01 | 982.05 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 18282.0
|
107.94 (REGN) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 | 4 | Ryan Arthur F | DIRECTOR | dsp | 100.0 | 0.55 | 0.01 | 962.53 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 18182.0
|
107.94 (REGN) |
| 2024-05-03 | 2024-05-01 | 2024-05-01 | 4 | Ryan Arthur F | DIRECTOR | dsp | 100.0 | 0.55 | 0.01 | 899.61 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 18082.0
|
108.37 (REGN) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Ryan Arthur F | DIRECTOR | acq | 1607.0 | 100.0 | 0.15 | 888.34 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code A | 1607.0 | 107.13 (REGN) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)